Matches in Nanopublications for { ?s ?p "[Primary (de novo) glioblastomas develop in older patients and are characterized by epidermal growth factor (EGF) receptor amplification/overexpression, p16 deletion, and PTEN mutations, whereas secondary glioblastomas that progressed from low-grade or anaplastic astrocytoma develop in younger patients and frequently contain p53 mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP315311.RAkiBH9B7aGpW1Aj4nq6ccX4sKw_WMbFRIcGm8450ZDgY130_assertion description "[Primary (de novo) glioblastomas develop in older patients and are characterized by epidermal growth factor (EGF) receptor amplification/overexpression, p16 deletion, and PTEN mutations, whereas secondary glioblastomas that progressed from low-grade or anaplastic astrocytoma develop in younger patients and frequently contain p53 mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP315311.RAkiBH9B7aGpW1Aj4nq6ccX4sKw_WMbFRIcGm8450ZDgY130_provenance.
- assertion description "[Primary (de novo) glioblastomas develop in older patients and are characterized by epidermal growth factor (EGF) receptor amplification/overexpression, p16 deletion, and PTEN mutations, whereas secondary glioblastomas that progressed from low-grade or anaplastic astrocytoma develop in younger patients and frequently contain p53 mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Primary (de novo) glioblastomas develop in older patients and are characterized by epidermal growth factor (EGF) receptor amplification/overexpression, p16 deletion, and PTEN mutations, whereas secondary glioblastomas that progressed from low-grade or anaplastic astrocytoma develop in younger patients and frequently contain p53 mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP274474.RAkRpzsxMJbpkE79aczNFU4Y6Q4YX00cmkZxMNV2qgrJE130_assertion description "[Primary (de novo) glioblastomas develop in older patients and are characterized by epidermal growth factor (EGF) receptor amplification/overexpression, p16 deletion, and PTEN mutations, whereas secondary glioblastomas that progressed from low-grade or anaplastic astrocytoma develop in younger patients and frequently contain p53 mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP274474.RAkRpzsxMJbpkE79aczNFU4Y6Q4YX00cmkZxMNV2qgrJE130_provenance.
- NP274467.RAEV9pu0WwXnq6IW3hyqDgR67c_mPkroPIERSVyqIPclA130_assertion description "[Primary (de novo) glioblastomas develop in older patients and are characterized by epidermal growth factor (EGF) receptor amplification/overexpression, p16 deletion, and PTEN mutations, whereas secondary glioblastomas that progressed from low-grade or anaplastic astrocytoma develop in younger patients and frequently contain p53 mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP274467.RAEV9pu0WwXnq6IW3hyqDgR67c_mPkroPIERSVyqIPclA130_provenance.